Picture of Soligenix logo

SNGX — Soligenix News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeMicro CapSucker Stock

Brief: Soligenix Announces European Patent Grant For Use Of Dusquetide In Oral Mucositis

Soligenix Inc  SNGX.O :
    * SOLIGENIX ANNOUNCES EUROPEAN PATENT GRANT FOR USE OF
DUSQUETIDE
IN ORAL MUCOSITIS

Source text for Eikon:  ID:nPnbxk1nka 
Further company coverage:  SNGX.O

Recent news on Soligenix

See all news